Meningococcal (Groups A, C, Y, W) Conjugate Vaccine (MenQuadfi) Report issue

Active Ingredient History

  • Now
Meningococcal vaccine refers to any vaccine used to prevent infection by Neisseria meningitidis. Different versions are effective against some or all of the following types of meningococcus: A, B, C, W-135, and Y. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.   Wikipedia

More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data
4cmenb vaccine | acwyvax | bexsero | conjugated meningococcal acwy-tt | group c meningococcal polysaccharide-tetansu toxoid conjugate | gsk3536820a | mcv-acyw135 vaccine | menabcwy | menactra | menacwy | menacwy conjugate vaccine | menacwy-crm | menacwy-crm197 | menacwy-ps | menacwy vaccine | men-acyw135 | mencevax | menc-tt | meningococcal group a, c, w-135 and y conjugate vaccine | meningococcal polysaccharide diphtheria toxoid conj. | meningococcal polysaccharide (serogroups a, c, y and w-135) diphtheria toxoid conjugate vaccine | meningococcal polysaccharide tetanus protein conjugate | neisseria meningitidis serogroup a polysaccharide conjugated to tetanus toxoid / neisseria meningitidis serogroup c polysaccharide conjugated to tetanus toxoid /neisseria meningitidis serogroup w-135 polysaccharide conjugated to tetanus toxoid / neisseria meningitidis serogroup y polysaccharide conjugated to tetanus toxoid | nimenrix


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue